Perez-Lopez A, Behnsen J, Nuccio SP, Raffatellu M. Mucosal immunity to pathogenic intestinal bacteria. Nat Rev Immunol. 2016;16:135–48.

Article  CAS  PubMed  Google Scholar 

Bushyhead D, Quigley EM. Small intestinal bacterial overgrowth. Gastroenterol Clin North Am. 2021;50:463–74.

Article  PubMed  Google Scholar 

Bushyhead D, Quigley EMM. Small intestinal bacterial overgrowth-pathophysiology and its implications for definition and management. Gastroenterology. 2022;163:593–607.

Article  PubMed  Google Scholar 

Gandhi A, Shah A, Jones MP, Koloski N, Talley NJ, Morrison M, et al. Methane positive small intestinal bacterial overgrowth in inflammatory bowel Disease and irritable bowel syndrome: a systematic review and meta-analysis. Gut Microbes. 2021;13:1933313.

Article  PubMed  PubMed Central  Google Scholar 

Gurusamy SR, Shah A, Talley NJ, Koloski N, Jones MP, Walker MM, et al. Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and Meta-analysis. Am J Gastroenterol. 2021;116:935–42.

Article  CAS  PubMed  Google Scholar 

El Kurdi B, Babar S, El Iskandarani M, Bataineh A, Lerch MM, Young M, et al. Factors that affect prevalence of small intestinal bacterial overgrowth in chronic Pancreatitis: a systematic review, Meta-analysis, and Meta-Regression. Clin Transl Gastroenterol. 2019;10:e00072.

Article  PubMed  PubMed Central  Google Scholar 

Maslennikov R, Pavlov C, Ivashkin V. Small intestinal bacterial overgrowth in Cirrhosis: systematic review and meta-analysis. Hepatol Int. 2018;12:567–76.

Article  PubMed  Google Scholar 

Gudan A, Jamiol-Milc D, Hawrylkowicz V, Skonieczna-Zydecka K, Stachowska E. The prevalence of small intestinal bacterial overgrowth in patients with non-alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A systematic review, Meta-analysis and Meta-regression. Nutrients. 2022;14.

Feng X, Li XQ. The prevalence of small intestinal bacterial overgrowth in Diabetes Mellitus: a systematic review and meta-analysis. Aging. 2022;14:975–88.

Article  PubMed  PubMed Central  Google Scholar 

Feng X, Li XQ, Jiang Z. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol. 2021;40:3039–51.

Article  PubMed  Google Scholar 

Li X, Feng X, Jiang Z. Association of small intestinal bacterial overgrowth with Parkinson’s Disease: a systematic review and meta-analysis. Gut Pathog. 2021;13:25.

Article  PubMed  PubMed Central  Google Scholar 

Patel SM, Young MC. The identification and management of small intestinal bacterial overgrowth: a Functional Medicine Approach. Phys Med Rehabil Clin N Am. 2022;33:587–603.

Article  PubMed  Google Scholar 

Skrzydlo-Radomanska B, Cukrowska B. How to recognize and treat small intestinal bacterial overgrowth? J Clin Med. 2022;11.

de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, et al. Pathogenesis and clinical management of Helicobacter pylori gastric Infection. World J Gastroenterol. 2019;25:5578–89.

Article  PubMed  PubMed Central  Google Scholar 

Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and gastric Cancer: pathogenetic mechanisms. Int J Mol Sci. 2023;24.

Fujimori S. Progress in elucidating the relationship between Helicobacter pylori Infection and intestinal Diseases. World J Gastroenterol. 2021;27:8040–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu D, Wang M, Ke X, Wang Q, Wang J, Li D. Association between H. Pylori Infection and colorectal polyps: a Meta-analysis of Observational studies. Front Med (Lausanne). 2021;8:706036.

Article  PubMed  Google Scholar 

Zuo Y, Jing Z, Bie M, Xu C, Hao X, Wang B. Association between Helicobacter pylori Infection and the risk of Colorectal cancer: a systematic review and meta-analysis. Med (Baltim). 2020;99:e21832.

Article  Google Scholar 

Wang C, Yin Y, Wang L, Guo X, Liu L, Qi X. Association between Helicobacter pylori Infection and irritable bowel syndrome: a systematic review and meta-analysis. Postgrad Med J. 2021.

Chen CC, Liou JM, Lee YC, Hong TC, El-Omar EM, Wu MS. The interplay between Helicobacter pylori and gastrointestinal microbiota. Gut Microbes. 2021;13:1–22.

Article  PubMed  PubMed Central  Google Scholar 

Bakhti SZ, Latifi-Navid S. Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis. BMC Microbiol. 2021;21:258.

Article  PubMed  PubMed Central  Google Scholar 

Dharan M, Wozny D. Helicobacter pylori Infection and small intestinal bacterial overgrowth-more than what meets the eye. World J Clin Cases. 2022;10:7209–14.

Article  PubMed  PubMed Central  Google Scholar 

Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E, et al. The role of small intestinal bacterial overgrowth in Parkinson’s Disease. Mov Disord. 2013;28:1241–9.

Article  CAS  PubMed  Google Scholar 

Gravina A, Federico A, Ruocco E, Lo Schiavo A, Masarone M, Tuccillo C, et al. Helicobacter pylori Infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United Eur Gastroenterol J. 2015;3:17–24.

Article  Google Scholar 

Del Zompo F, Ojetti V, Feliciani D, Mangiola F, Petruzziello C, Tesori V, et al. Helicobacter pylori Infection is associated with high methane production during lactulose breath test. Eur Rev Med Pharmacol Sci. 2016;20:3452–6.

PubMed  Google Scholar 

Enko D, Kriegshauser G. Functional (13)C-urea and glucose hydrogen/methane breath tests reveal significant association of small intestinal bacterial overgrowth in individuals with active Helicobacter pylori Infection. Clin Biochem. 2017;50:46–9.

Article  CAS  PubMed  Google Scholar 

Mujeeb VR, Prasad AS, Anadure RK, Mishra AB, Pillai V. A study on chronic Proton pump inhibitor usage and small intestinal bacterial overgrowth (SIBO). J Clin Diagn Res. 2019;13:14–7.

Google Scholar 

Radionova TO, Skrypnyk IM, Maslova GS, Do H. Pylori status and small intestinal bacterial overgrowth determine the clinical course of chronic active gastritis in patients with type 2 Diabetes Mellitus? Wiad Lek. 2020;73:1223–8.

Article  PubMed  Google Scholar 

Kim DB, Jo IH, Paik CN, Kim YJ, Lee JM. Serum pepsinogen and gastrin levels: Reliable markers to predict small intestinal bacterial overgrowth. Turk J Gastroenterol. 2022;33:213–20.

Article  PubMed  PubMed Central  Google Scholar 

Zhu D, Wang XL, Dai Y, Li SY, Wang WH. Influence of Helicobacter pylori Infection and its eradication treatment on small intestinal bacterial overgrowth. Zhonghua Yi Xue Za Zhi. 2022;102:3382–7.

CAS  PubMed  Google Scholar 

Wang J, Zhang L, Hou X. Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2021;15:1385–99.

Article  CAS  PubMed  Google Scholar 

Su T, Lai S, Lee A, He X, Chen S. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth. J Gastroenterol. 2018;53:27–36.

Article  CAS  PubMed  Google Scholar 

Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115:165–78.

Article  PubMed  Google Scholar 

Binicier OB, Hakim GD, Unlu SM, Topalak OS. High-resolution magnified endoscopy combined with flexible spectral imagining colour enhancement techniques in the diagnosis of Helicobacter pylori Disease. Prz Gastroenterol. 2019;14:202–10.

CAS  PubMed  PubMed Central  Google Scholar 

Jacobs JP, Lagishetty V, Hauer MC, Labus JS, Dong TS, Toma R, et al. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes. Microbiome. 2023;11:5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Article  PubMed  PubMed Central  Google Scholar 

Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for systematic reviews of interventions version 6.2. The Cochrane Collaboration; 2021. www.training.cochrane.org/handbook.

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010;http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

Article  PubMed  Google Scholar 

Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008;37:1148–57.

Article  PubMed  PubMed Central  Google Scholar 

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

Article  CAS  PubMed  PubMed Central  Google Scholar